全文获取类型
收费全文 | 2601篇 |
免费 | 117篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 29篇 |
儿科学 | 48篇 |
妇产科学 | 114篇 |
基础医学 | 225篇 |
口腔科学 | 15篇 |
临床医学 | 229篇 |
内科学 | 575篇 |
皮肤病学 | 36篇 |
神经病学 | 133篇 |
特种医学 | 267篇 |
外科学 | 326篇 |
综合类 | 9篇 |
一般理论 | 2篇 |
预防医学 | 211篇 |
眼科学 | 41篇 |
药学 | 120篇 |
中国医学 | 7篇 |
肿瘤学 | 346篇 |
出版年
2023年 | 11篇 |
2022年 | 27篇 |
2021年 | 54篇 |
2020年 | 30篇 |
2019年 | 36篇 |
2018年 | 39篇 |
2017年 | 23篇 |
2016年 | 53篇 |
2015年 | 60篇 |
2014年 | 91篇 |
2013年 | 107篇 |
2012年 | 146篇 |
2011年 | 157篇 |
2010年 | 80篇 |
2009年 | 71篇 |
2008年 | 114篇 |
2007年 | 128篇 |
2006年 | 140篇 |
2005年 | 154篇 |
2004年 | 138篇 |
2003年 | 114篇 |
2002年 | 137篇 |
2001年 | 104篇 |
2000年 | 102篇 |
1999年 | 84篇 |
1998年 | 29篇 |
1997年 | 31篇 |
1996年 | 20篇 |
1995年 | 26篇 |
1994年 | 17篇 |
1993年 | 18篇 |
1992年 | 50篇 |
1991年 | 39篇 |
1990年 | 40篇 |
1989年 | 23篇 |
1988年 | 22篇 |
1987年 | 24篇 |
1986年 | 19篇 |
1985年 | 20篇 |
1984年 | 9篇 |
1983年 | 12篇 |
1980年 | 9篇 |
1979年 | 15篇 |
1976年 | 7篇 |
1974年 | 7篇 |
1973年 | 15篇 |
1971年 | 11篇 |
1970年 | 9篇 |
1967年 | 6篇 |
1966年 | 9篇 |
排序方式: 共有2733条查询结果,搜索用时 15 毫秒
31.
Catalano OA Hahn PF Hooper DC Mueller PR 《AJR. American journal of roentgenology》2000,175(2):533-536
OBJECTIVE: We reviewed a 4-year experience draining fluid collections infected with vancomycin-resistant enterococci to determine the outcome of percutaneous intervention in patients with this highly resistant and increasingly common organism. MATERIALS AND METHODS: Charts of patients from whom vancomycin-resistant enterococci had been isolated during percutaneous drainage were reviewed to determine patient response to drainage, catheter management, and outcome of treatment. RESULTS: Twenty-one patients underwent percutaneous drainage of 28 fluid collections from which vancomycin-resistant enterococci were isolated, including 16 intraabdominal abscesses, seven biliary or urinary obstructions, and five empyemas. The drainage of 27 (96%) of 28 collections were technically successful. In seven patients, drainage provided the first isolation of vancomycin-resistant enterococci from the patient. Five patients also had blood cultures with positive findings for vancomycin-resistant enterococci, and 14 collections were coinfected with other bacteria or with fungi. Twenty collections (71%) or obstructions were successfully treated with percutaneous drainage. Drainage was unsuccessful in treating eight collections in seven patients. CONCLUSION: Despite high-level antibiotic resistance, fluid collections infected with vancomycin-resistant enterococci can be successfully drained percutaneously, resulting in a favorable likelihood of recovery for patients. 相似文献
32.
Daniel G Haller Paul J Catalano John S Macdonald Mark A O'Rourke Michael S Frontiera Don V Jackson Robert J Mayer 《Journal of clinical oncology》2005,23(34):8671-8678
PURPOSE: In 1990, fluorouracil (FU) plus levamisole for 1 year became standard adjuvant treatment for patients with high-risk stages II and III colon cancer. Intergroup (INT) 0089 assessed the relative contributions of leucovorin and levamisole in such patients. PATIENTS AND METHODS: From 1988 to 1992, 3,794 patients were randomly assigned. Experimental treatment consisted of one of three chemotherapy regimens: the low-dose leucovorin plus FU (Mayo Clinic; LDLV) regimen, the high-dose leucovorin plus FU (Roswell Park; HDLV) regimen, and the low-dose leucovorin plus levamisole plus FU (LDLV plus LEV) regimen, each administered for 30 to 32 weeks. The control arm was levamisole plus FU (LEV) for 1 year. RESULTS: After a median follow-up of 10 years, of 3,561 eligible patients, 1,691 (47%) have died and 1,330 (37%) have experienced disease recurrence; 137 (10%) of those experiencing recurrence are still alive. A total of 481 patients (13%) died without evidence of recurrence, and 1,723 (48%) are alive and disease free. Although there were toxicity differences among the four arms, none was statistically superior in disease-free or overall survival. CONCLUSION: The 6- to 8-month regimens of LDLV and HDLV without levamisole used in this trial, rather than the previous standard regimen of 12 months of LEV, have become widely used. INT-0089 has long-term follow-up of the largest clinical trial of patients with high-risk colon cancer, documenting not only the durability of the treatment effects, but also the natural history of patients with high-risk colon cancer, and analyses of treatment based on age, race, and comorbid conditions such as obesity, diabetes, and second primary cancers. 相似文献
33.
Osorio E Arango GJ Jiménez N Alzate F Ruiz G Gutiérrez D Paco MA Giménez A Robledo S 《Journal of ethnopharmacology》2007,111(3):630-635
Ethnobotanical and chemotaxonomical studies for antiparasitic activity of Colombian Annonaceae were carried out. In vitro antiprotozoal activity of 36 extracts obtained from six different species was determined against promastigotes of three Leishmania species, epimastigotes of Trypanosoma cruzi and both chloroquine sensitive (F32) and resistant (W2) Plasmodium falciparum. Cytotoxic activity was evaluated in U-937 cells. Active extracts were selected according their selectivity index (SI). Extracts from Annona muricata, Rollinia exsucca, Rollinia pittieri and Xylopia aromatica were active against Leishmania spp. and Trypanosoma cruzi showing IC50 values lower than 25 microg/ml. Hexane extract from Rollinia pittieri leaves was the most selective against Trypanosoma cruzi and Leishmania spp. (IS=10 and 16, respectively). The extracts from Desmopsis panamensis, Pseudomalmea boyacana, Rollinia exsucca and Rollinia pittieri showed good antiplasmodial activity (IC50 < 10 microg/ml). No correlation between antiplasmodial activity and inhibition of beta-hematin production was found. The present study gives specific and useful information about antiprotozoal and cytotoxic activities of some Annonaceae extracts. Results presented here also demonstrate which plants and/or plant parts could be useful in the treatment of leishmaniasis, Chagas' disease and malaria. 相似文献
34.
35.
36.
37.
38.
Leonardo Pace Emanuele Nicolai Angelo Luongo Marco Aiello Onofrio A. Catalano Andrea Soricelli Marco Salvatore 《European journal of radiology》2014
Purpose
To compare the performance of PET/MRI imaging using MR attenuation correction (MRAC) (DIXON-based 4-segment -map) in breast cancer patients with that of PET/CT using CT-based attenuation correction and to compare the quantification accuracy in lesions and in normal organ tissues.Methods
A total of 36 patients underwent a whole-body PET/CT scan 1 h after injection and an average of 62 min later a second scan using a hybrid PET/MRI system. PET/MRI and PET/CT were compared visually by rating anatomic allocation and image contrast. Regional tracer uptake in lesions was quantified using volumes of interest, and maximal and mean standardized uptake values (SUVmax and SUVmean, respectively) were calculated. Metabolic tumor volume (MTV) of each lesion was computed on PET/MRI and PET/CT. Tracer uptake in normal organ tissue was assessed as SUVmax and SUVmean in liver, spleen, left ventricular myocardium, lung, and muscle.Results
Overall 74 FDG positive lesions were visualized by both PET/CT and PET/MRI. No significant differences in anatomic allocation scores were found between PET/CT and PERT/MRI, while contrast score of lesions on PET/MRI was significantly higher. Both SUVmax and SUVmean of lesions were significantly higher on PET/MRI than on PET/CT, with strong correlations between PET/MRI and PET/CT data (ρ = 0.71–0.88). MTVs of all lesions were 4% lower on PET/MRI than on PET/CT, but no statistically significant difference was observed, and an excellent correlation between measurements of MTV with PET/MRI and PET/CT was found (ρ = 0.95–0.97; p < 0.0001). Both SUVmax and SUVmean were significantly lower by PET/MRI than by PET/CT for lung, liver and muscle, no significant difference was observed for spleen, while either SUVmax and SUVmean of myocardium were significantly higher by PET/MRI. High correlations were found between PET/MRI and PET/CT for both SUVmax and SUVmean of the left ventricular myocardium (ρ = 0.91; p < 0.0001), while moderate correlations were found for the other normal organ tissues (ρ = 0.36–0.61; p < 0.05).Conclusions
PET/MRI showed equivalent performance in terms of qualitative lesion detection to PET/CT. Despite significant differences in tracer uptake quantification, due to either methodological and biological factors, PET/MRI and PET/CT measurements in lesions and normal organ tissues correlated well. This study demonstrates that integrated whole-body PET/MRI is feasible in a clinical setting with high quality and in a short examination time. 相似文献39.
Filippo Catalano Antonello Trecca Luca Rodella Francesco Lombardo Anna Tomezzoli Serena Battista Marco Silano Fabio Gaj Giovanni de Manzoni 《Surgical endoscopy》2009,23(7):1581-1586
Background Endoscopic submucosal dissection (ESD) has been developed as treatment for early gastric cancer (EGC) by Japanese authors.
However, there are no reports about its possible implementation in the Western setting. The aim of the present work is to
determine the safety and efficacy of the endoscopic treatments for EGC in an Italian cohort.
Methods Forty-five patients for a total of 48 gastric lesions were enrolled in the study. Thirty-six EMR procedures were performed
with the strip biopsy technique using a double-channel endoscope. En bloc resection refers to resection in one piece, while
piecemeal refers to resections in which the lesion was removed in multiple fragments. A total of 12 ESD were performed and
completed with IT knife. We define as curative treatment lateral and vertical margins of the resected specimens free of cancer
and repeat endoscopic finding of no recurrent disease.
Results Out of 36 EMR procedures, 10 were piecemeal resections (28%), while 26 were en bloc (72%). ESD led to en bloc resection in
11/12 cases (92%). Histological assessment of curability in the EMR group was achieved in 56% of the cases, and in 92% of
the ESD group. Mean follow-up period was 31 months (range: 12–71 months). There was no local recurrence or distant metastasis
in the curative group patients.
Conclusions These results seem to confirm the safety and the clinical efficacy of the ESD procedure in the Western world too. 相似文献
40.
The insulinogenic effect ofl-arginine has been demonstrated bothin vivo andin vitro, but the mechanism by which this amino acid stimulates the pancreatic B-cells to release insulin is not entirely clear. Recently it was shown thatl-arginine-derived nitric oxide may mediatel-arginine-induced insulin release, and data were also provided to suggest that nitric oxide (NO) has no part in this process. To further investigate whether NO is involved in the release of insulin induced byl-arginine, we infused different doses ofl- andd-arginine in rats. L-Arginine (25 and 100 mg/kg/minute) elicited dose-dependent increases of the plasma insulin levels by up to 18.65±2.13 and 48.6±6.6 U/L, respectively, and increased the plasma glucose levels by up to 1.18±0.13 and 1.43±0.1 mmol/L, respectively. D-Arginine (25 and 100 mg/kg/minute) also elicited dose-dependent increases of the plasma insulin levels by up to 9.08±1.23 and 23.33±2.33 U/L, and increased the plasma glucose levels by up to 0.32±0.09 and 0.46±0.08 mmol/L. Thus, the increases in plasma insulin and glucose levels were significantly smaller during infusion ofd-arginine. We conclude that the plasma insulin response to i.v. infusion ofl-arginine is at least partly mediated by augmented NO synthesis by the pancreatic islets, althoughl-arginine-derived NO is not an obligatory stimulus for insulin release. 相似文献